Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura E Pope

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Current Medical Research and Opinion|July 26, 2014
An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditionsGary L Pattee, James P Wymer, Catherine Lomen-Hoerth, et al.
Clinical Therapeutics|December 13, 2006
Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation studyRonald A Thisted, Leslie Klaff, Sherwyn L Schwartz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 4, 2017
Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's diseaseSusan H Fox, Leonard Verhagen Metman, John G Nutt, et al.
Annals of Neurology|April 25, 2006
Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosisHillel S Panitch, Ronald A Thisted, Richard A Smith, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Current Medical Research and Opinion|July 26, 2014
An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditionsGary L Pattee, James P Wymer, Catherine Lomen-Hoerth, et al.
Clinical Therapeutics|December 13, 2006
Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation studyRonald A Thisted, Leslie Klaff, Sherwyn L Schwartz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 4, 2017
Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's diseaseSusan H Fox, Leonard Verhagen Metman, John G Nutt, et al.
Annals of Neurology|April 25, 2006
Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosisHillel S Panitch, Ronald A Thisted, Richard A Smith, et al.
Pageof 2